Full Breakdown
FDA Recalls Hundreds of Thousands of Eye Drop Bottles Over Sterility Concerns
By Drooid · · How we work
Recall Details
The U.S. Food and Drug Administration announced a voluntary recall of multiple eye-drop products after identifying potential sterility issues. The recall covers several lot numbers of lubricating eye drops produced by Cameron Pharmaceuticals and AvKare. Specific items include 0.125 oz (3.5 g) tubes of Cameron Pharmaceuticals Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%) and 0.5 fl oz (15 mL) bottles of the same formulation, as well as 0.5 fl oz (15 mL) and 1.0 fl oz (30 mL) twin-pack solutions from AvKare.
Reason for Recall
The FDA’s investigation indicated that the affected lots may not meet sterility standards required for ophthalmic solutions. While the agency has not disclosed the precise nature of the contamination risk, it emphasized that non-sterile eye drops could pose infection hazards to users.
Affected Products and Quantities
- Cameron Pharmaceuticals Lubricant Eye Drops, 0.125 oz tubes, Lot # 3183
- Cameron Pharmaceuticals Lubricant Eye Drops, 0.5 fl oz bottles, Lot # 3163 (expiry 8/31/2026) and Lot # 3164 (expiry 9/30/2026)
- AvKare Carboxymethylcellulose Sodium Ophthalmic Solution, 0.5 % sterile, 0.5 fl oz bottles, 1.0 fl oz twin-pack, various lot numbers
The FDA’s notice indicates that the combined volume of recalled product reaches “hundreds of thousands” of bottles, though an exact count was not provided.
Official Response
The FDA instructed consumers who have purchased any of the listed eye-drop products to verify the lot numbers on their packaging and discontinue use of any recalled items. The agency recommended returning the products to the place of purchase for a refund or contacting the manufacturers for further instructions. No reports of adverse health events linked to the recalled lots have been confirmed at this time.
Potential Impact and Consumer Guidance
Because eye drops are applied directly to the ocular surface, the presence of non-sterile material could increase the risk of eye infections, irritation, or inflammation. Health professionals are advised to inform patients of the recall and suggest alternative sterile lubricants if needed. Consumers are urged to check their medicine cabinets promptly and follow the FDA’s disposal or return guidance to mitigate any possible health risks.
